|Reduced rate of disease development after HIV-2 infection as compared to HIV-1|
R Marlink, P Kanki, I Thior, K Travers, G Eisen, T Siby, I Traore, CC Hsieh, ...
Science 265 (5178), 1587-1590, 1994
|Slower heterosexual spread of HIV-2 than HIV-1|
PJ Kanki, KU Travers, RG Marlink, ME Essex, S MBoup, A Gueye-NDiaye, ...
The Lancet 343 (8903), 943-946, 1994
|Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2|
SJ Popper, AD Sarr, KU Travers, A Gueye-Ndiaye, S Mboup, ME Essex, ...
The Journal of infectious diseases 180 (4), 1116-1121, 1999
|Natural protection against HIV-1 infection provided by HIV-2|
K Travers, S Mboup, R Marlink, A Gueye-Nidaye, T Siby, I Thior, I Traore, ...
Science 268 (5217), 1612-1615, 1995
|Morbidity of infections caused by antimicrobial-resistant bacteria|
K Travers, B Michael
Clinical Infectious Diseases 34 (Supplement_3), S131-S134, 2002
|Human T-lymphotropic virus type 4 and the human immunodeficiency virus in West Africa|
PJ Kanki, S M'boup, D Ricard, F Barin, F Denis, C Boye, L Sangare, ...
Science 236 (4803), 827-831, 1987
|Excess infections due to antimicrobial resistance: the “Attributable Fraction”|
M Barza, K Travers
Clinical Infectious Diseases 34 (Supplement_3), S126-S130, 2002
|Humanistic and economic burden of generalized anxiety disorder in North America and Europe|
DA Revicki, K Travers, KW Wyrwich, H Svedsäter, J Locklear, MS Mattera, ...
Journal of affective disorders 140 (2), 103-112, 2012
|Prevalence and risk determinants of human immunodeficiency virus type 2 (HIV-2) and human immunodeficiency virus type 1 (HIV-1) in west African female prostitutes|
P Kanki, S M'Boup, R Marlink, K Travers, CC Hsieh, A Gueye, C Boye, ...
American journal of epidemiology 136 (7), 895-907, 1992
|The Need to Improve Antimicrobial Use in Agriculture: Ecological and Human Health Consequences. A Report of the Facts about Antibiotics in Animals and the Impact on Resistance …|
M Barza, SL Gorbach
Clinical infectious diseases 34, 2002
|Integrating Escherichia coli antimicrobial susceptibility data from multiple surveillance programs|
JM Stelling, K Travers, RN Jones, PJ Turner, TF O'Brien, SB Levy
Emerging infectious diseases 11 (6), 873, 2005
|Review of assessments of the human health risk associated with the use of antimicrobial agents in agriculture|
JC Bailar III, K Travers
Clinical Infectious Diseases 34 (Supplement_3), S135-S143, 2002
|Clusters of lymphoma in ferrets|
SE Erdman, PJ Kanki, FM Moore, SA Brown, TA Kawasaki, KW Mikule, ...
Cancer investigation 14 (3), 225-230, 1996
|A systematic literature review and network meta-analysis of treatments for patients with untreated multiple myeloma not eligible for stem cell transplantation|
K Weisel, C Doyen, M Dimopoulos, A Yee, JJ Lahuerta, A Martin, ...
Leukemia & lymphoma 58 (1), 153-161, 2017
|Burden and management of chronic kidney disease in Japan: systematic review of the literature|
K Travers, A Martin, Z Khankhel, KS Boye, LJ Lee
International Journal of Nephrology and Renovascular Disease 6, 1, 2013
|Interaction with human immunodeficiency virus (HIV) type 2 predicts HIV type 1 genotype|
AD Sarr, JL Sankalé, DJ Hamel, KU Travers, A Guèye-Ndiaye, M Essex, ...
Virology 268 (2), 402-410, 2000
|Protection from HIV-1 infection by HIV-2.|
KU Travers, GE Eisen, RG Marlink, ME Essex, CC Hsieh, S Mboup, ...
AIDS (London, England) 12 (2), 224, 1998
|HIV-2 and natural protection against HIV-1 infection|
AE Greenberg, SZ Wiktor, KM DeCock, P Smith, HW Jaffe, TJ Dondero Jr, ...
SCIENCE-NEW YORK THEN WASHINGTON-, 1959-1959, 1996
|Risk factors for HIV-1 and HIV-2 infection in pregnant women in Dakar, Senegal.|
RC Abbott, A NDour-Sarr, A Diouf, T NDoye, D Bâ, N Tall, N MBaye, ...
Journal of acquired immune deficiency syndromes 7 (7), 711-717, 1994
|Absence of antibodies to HIV-2/HTLV-4 in six central African nations|
PJ Kanki, J ALLAN, F BARIN, R REDFIELD, N CLUMECK, T QUINN, ...
AIDS research and human retroviruses 3 (3), 317-322, 1987